← Open Payments lookup

GODOFREDO ROSSI: Open Payments

NPI 1225073901 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,982 in 188 payments from 39 companies in 2025. Trend: 2023 $4,327 · 2024 $3,725 · 2025 $3,982

Food & beverage: $3,946Education: $36
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation22$401
Biogen, Inc.12$275
SK Life Science, Inc.12$269
Otsuka America Pharmaceutical, Inc.14$230
Novo Nordisk Inc5$202
ARGENX US, INC.6$199
Alexion Pharmaceuticals, Inc.4$190
Eisai Inc.4$183
Abbott Laboratories10$180
Janssen Biotech, Inc.6$167

Products named: KESIMPTA, REXULTI, VYVGART HYTRULO, VUMERITY, ULTOMIRIS, Leqembi, Ozempic, INFINITY.

Industry payments across TX — which companies pay providers there.